Increased platelet concentration does not improve functional graft healing in bio‐enhanced ACL reconstruction
- 18 March 2014
- journal article
- knee
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 23 (4) , 1161-1170
Abstract
Purpose: The use of an extracellular matrix scaffold (ECM) combined with platelets to enhance healing of an anterior cruciate ligament (ACL) graft (“bio‐enhanced ACL reconstruction”) has shown promise in animal models. However, the effects of platelet concentration on graft healing remain unknown. The objectives of this study were to determine whether increasing the platelet concentration in the ECM scaffold would (1) improve the graft biomechanical properties and (2) decrease cartilage damage after surgery.Methods: Fifty‐five adolescent minipigs were randomized to five treatment groups: untreated ACL transection (n = 10), conventional ACL reconstruction (n = 15) and bio‐enhanced ACL reconstruction using 1× (n = 10), 3× (n = 10) or 5× (n = 10) platelet‐rich plasma. The graft biomechanical properties, anteroposterior (AP) knee laxity, graft histology and macroscopic cartilage integrity were measured at 15 weeks.Results: The mean linear stiffness of the bio‐enhanced ACL reconstruction procedure using the 1× preparation was significantly greater than traditional reconstruction, while the 3× and 5× preparations were not. The failure loads of all the ACL‐reconstructed groups were equivalent but significantly greater than untreated ACL transection. There were no significant differences in the Ligament Maturity Index or AP laxity between reconstructed knees. Macroscopic cartilage damage was relatively minor, though significantly less when the ECM‐platelet composite was used.Conclusions: Only the 1× platelet concentration improved healing over traditional ACL reconstruction. Increasing the platelet concentration from 1× to 5× in the ECM scaffold did not further improve the graft mechanical properties. The use of an ECM‐platelet composite decreased the amount of cartilage damage seen after ACL surgery.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health (1RO1‐AR056834, 1RO1‐AR056834S1 (ARRA), 2R01‐AR054099, 2P20‐GM104937)
This publication has 60 references indexed in Scilit:
- Biomechanical Outcomes After Bioenhanced Anterior Cruciate Ligament Repair and Anterior Cruciate Ligament Reconstruction Are Equal in a Porcine ModelArthroscopy, 2012
- The Effect of Platelet Concentrates on Graft Maturation and Graft‐Bone Interface Healing in Anterior Cruciate Ligament Reconstruction in Human Patients: A Systematic Review of Controlled TrialsArthroscopy, 2011
- Reduced platelet concentration does not harm PRP effectiveness for ACL repair in a porcine in vivo modelJournal of Orthopaedic Research, 2011
- Age dependence of expression of growth factor receptors in porcine ACL fibroblastsJournal of Orthopaedic Research, 2010
- Immature animals have higher cellular density in the healing anterior cruciate ligament than adolescent or adult animalsJournal of Orthopaedic Research, 2010
- Comparison of Magnetic Resonance Imaging Findings in Anterior Cruciate Ligament Grafts With and Without Autologous Platelet‐Derived Growth FactorsArthroscopy, 2010
- The effect of skeletal maturity on the regenerative function of intrinsic ACL cellsJournal of Orthopaedic Research, 2009
- TRITON‐X is most effective among three decellularization agents for ACL tissue engineeringJournal of Orthopaedic Research, 2009
- Platelet‐rich plasma alone is not sufficient to enhance suture repair of the ACL in skeletally immature animals: An in vivo studyJournal of Orthopaedic Research, 2008
- Can suture repair of ACL transection restore normal anteroposterior laxity of the knee? An ex vivo studyJournal of Orthopaedic Research, 2008